The Future of Adjuvant Therapy in Breast Cancer

The idea of giving neoadjuvant therapy to resectable disease has been out there in breast cancer for a long time with her two and triple negative disease. I look at it from the perspective of if you know the patient is definitely going to need immune therapy and chemotherapy, giving it up front makes a lot of sense. Most of them we're now thinking about doing the new adjuvant treatment approach. We have these three trials where we have press releases and know that things are coming out shortly. There can be a whole lot of data to try to process. So so far checkmate 1816 PDL1 levels mattered quite a bit but everything about pporal app and metastatic